House Status:
Senate Status:
Senate Status:
Minutes for HB2596 - Committee on Public Health and Welfare
Short Title
Adding and removing certain substances in schedules I, II, IV and V of the uniform controlled substances act and making conforming changes to the criminal code definition of "fentanyl-related controlled substances."
Minutes Content for Tue, Mar 5, 2024
Chairperson Gossage opened the hearing on HB2596.
Jenna Moyer, Staff Revisor gave an overview of the bill. (Attachment 8) She answered questions from committee members.
Alexandra Blasi gave proponent testimony on HB2596. (Attachment 9) (Attachment 10)There were no questions.
Nick Reinecker testified as neutral on HB2596. (Attachment 11) (Attachment 12) (Attachment 13) (Attachment 14) There were no questions.
Written only, proponent testimony was submitted by:
Robert Stuart, Executive Officer, KBI (Attachment 15)
Chairperson Gossage closed the hearing on HB2596.
Chairperson adjourned the meeting at 9:20 a.m. The next scheduled meeting is March 6, 2025 at 8:30 a.m.
